Alzheimer’s disease (AD) is a progressive age-dependent disorder whose risk is affected by genetic factors. Better models for investigating early effects of risk factors such as apolipoprotein E (APOE) genotype are needed.
Objective:
To determine whether APOE genotype produces neuropathologies in an AD-susceptible neural system, we compared effects of human APOE ɛ3 (E3) and APOE ɛ4 (E4) alleles on the mouse olfactory epithelium.
Methods:
RNA-Seq using the STAR aligner and DESeq2, immunohistochemistry for activated caspase-3 and phosphorylated histone H3, glucose uptake after oral gavage of 2-[1,2-3H (N)]-deoxy-D-glucose, and Seahorse Mito Stress tests on dissociated olfactory mucosal cells.
Results:
E3 and E4 olfactory mucosae show 121 differentially abundant mRNAs at age 6 months. These do not indicate differences in cell type proportions, but effects on 17 odorant receptor mRNAs suggest small differences in tissue development. Ten oxidoreductases mRNAs important for cellular metabolism and mitochondria are less abundant in E4 olfactory mucosae but this does not translate into differences in cellular respiration. E4 olfactory mucosae show lower glucose uptake, characteristic of AD susceptibility and consistent with greater expression of the glucose-sensitive gene, Asns. Olfactory sensory neuron apoptosis is unaffected at age 6 months but is greater in E4 mice at 10 months.
Conclusion:
Effects of human APOE alleles on mouse olfactory epithelium phenotype are apparent in early adulthood, and neuronal loss begins to increase by middle age (10 months). The olfactory epithelium is an appropriate model for the ability of human APOE alleles to modulate age-dependent effects associated with the progression of AD.
CrewsL, MasliahE (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet19, R12–20.
2.
GrimmMOW, HartmannT (2012) Recent understanding of the molecular mechanisms of Alzheimer’s disease. J Addict Res TherS5, 004.
3.
AlzheimerA (1907) Uber eine eigenartige Erkankung der Hirnrinde. Psychisch-gerichtliche Medizin64, 146–148.
4.
CanterRG, PenneyJ, TsaiLH (2016) The road to restoring neural circuits for the treatment of Alzheimer’s disease. Nature539, 187–196.
5.
YuH, WuJ (2021) Amyloid-beta: A double agent in Alzheimer’s disease?Biomed Pharmacother139, 111575.
6.
NajAC, SchellenbergGD, Alzheimer’s Disease Genetics Consortium (2017) Genomic variants, genes, and pathways of Alzheimer’s disease: An overview. Am J Med Genet B Neuropsychiatr Genet174, 5–26.
CorderEH, SaundersAM, StrittmatterWJ, SchmechelDE, GaskellPC, SmallGW, RosesAD, HainesJL, Pericak-VanceMA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science261, 921–923.
12.
FarrerLA, CupplesLA, HainesJL, HymanB, KukullWA, MayeuxR, MyersRH, Pericak-VanceMA, RischN, van DuijnCM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA278, 1349–1356.
13.
BelloyME, NapolioniV, GreiciusMD (2019) A quarter century of APOE and Alzheimer’s disease: Progress to date and the path forward. Neuron101, 820–838.
14.
EichnerJE, DunnST, PerveenG, ThompsonDM, StewartKE, StroehlaBC (2002) Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review. Am J Epidemiol155, 487–495.
15.
MahleyRW, RallSCJr. (2000) Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet1, 507–537.
16.
XuQ, BernardoA, WalkerD, KanegawaT, MahleyRW, HuangY (2006) Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci26, 4985–4994.
17.
BertramL, TanziRE (2008) Thirty years of Alzheimer’s disease genetics: The implications of systematic meta-analyses. Nat Rev Neurosci9, 768–778.
18.
PhillipsMC (2014) Apolipoprotein E isoforms and lipoprotein metabolism. IUBMB Life66, 616–623.
19.
CorderEH, SaundersAM, RischNJ, StrittmatterWJ, SchmechelDE, GaskellPCJr., RimmlerJB, LockePA, ConneallyPM, SchmaderKE, SmallGW, RosesAD, HainesJL, Pericak-VanceMA (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet7, 180–184.
DotyRL, ReyesPF, GregorT (1987) Presence of both odor identification and detection deficits in Alzheimer’s disease. Brain Res Bull18, 597–600.
22.
PengKY, MathewsPM, LevyE, WilsonDA (2017) Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments. Neuroscience343, 364–371.
23.
GravesAB, BowenJD, RajaramL, McCormickWC, McCurrySM, SchellenbergGD, LarsonEB (1999) Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E epsilon4 status. Neurology53, 1480–1487.
24.
MesholamRI, MobergPJ, MahrRN, DotyRL (1998) Olfaction in neurodegenerative disease: A meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol55, 84–90.
25.
MobergPJ, DotyRL, MahrRN, MesholamRI, ArnoldSE, TuretskyBI, GurRE (1997) Olfactory identification in elderly schizophrenia and Alzheimer’s disease. Neurobiol Aging18, 163–167.
26.
MorganCD, MurphyC (2012) Individuals at risk for Alzheimer’s disease show differential patterns of ERP brain activation during odor identification. Behav Brain Funct8, 37.
27.
KowalewskiJ, MurphyC (2012) Olfactory ERPs in an odor/visual congruency task differentiate ApoE epsilon4 carriers from non-carriers. Brain Res1442, 55–65.
28.
OlofssonJK, JosefssonM, EkstromI, WilsonD, NybergL, NordinS, Nordin AdolfssonA, AdolfssonR, NilssonLG, LarssonM (2016) Long-term episodic memory decline is associated with olfactory deficits only in carriers of ApoE-small je, Ukrainian4. Neuropsychologia85, 1–9.
29.
GilbertPE, MurphyC (2004) The effect of the ApoE epsilon4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer’s disease, probable Alzheimer’s disease, and healthy elderly controls. J Clin Exp Neuropsychol26, 779–794.
30.
StanciuI, LarssonM, NordinS, AdolfssonR, NilssonLG, OlofssonJK (2014) Olfactory impairment and subjective olfactory complaints independently predict conversion to dementia: A longitudinal, population-based study. J Int Neuropsychol Soc20, 209–217.
31.
BaconAW, BondiMW, SalmonDP, MurphyC (1998) Very early changes in olfactory functioning due to Alzheimer’s disease and the role of apolipoprotein E in olfaction. Ann N Y Acad Sci855, 723–731.
32.
MurphyC, BaconAW, BondiMW, SalmonDP (1998) Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann N Y Acad Sci855, 744–750.
33.
LarssonM, SembH, WinbladB, AmberlaK, WahlundLO, BackmanL (1999) Odor identification in normal aging and early Alzheimer’s disease: Effects of retrieval support. Neuropsychology13, 47–53.
34.
MurphyC, GilmoreMM, SeeryCS, SalmonDP, LaskerBR (1990) Olfactory thresholds are associated with degree of dementia in Alzheimer’s disease. Neurobiol Aging11, 465–469.
35.
RoyetJP, CroisileB, Williamson-VastaR, HibertO, SercleratD, GuerinJ (2001) Rating of different olfactory judgements in Alzheimer’s disease. Chem Senses26, 409–417.
36.
SerbyM, LarsonP, KalksteinD (1991) The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry148, 357–360.
37.
HymanBT, ArriagadaPV, Van HoesenGW (1991) Pathologic changes in the olfactory system in aging and Alzheimer’s disease. Ann N Y Acad Sci640, 14–19.
PriceJL, DavisPB, MorrisJC, WhiteDL (1991) The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol Aging12, 295–312.
40.
ArnoldSE, LeeEB, MobergPJ, StutzbachL, KaziH, HanLY, LeeVM, TrojanowskiJQ (2010) Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease. Ann Neurol67, 462–469.
41.
TalamoBR, RudelR, KosikKS, LeeVM, NeffS, AdelmanL, KauerJS (1989) Pathological changes in olfactory neurons in patients with Alzheimer’s disease. Nature337, 736–739.
42.
CaoL, RickenbacherGT, RodriguezS, MouliaTW, AlbersMW (2012) The precision of axon targeting of mouse olfactory sensory neurons requires the BACE1 protease. Sci Rep2, 231.
43.
CaoL, SchrankBR, RodriguezS, BenzEG, MouliaTW, RickenbacherGT, GomezAC, LevitesY, EdwardsSR, GoldeTE, HymanBT, BarneaG, AlbersMW (2012) Abeta alters the connectivity of olfactory neurons in the absence of amyloid plaques in vivo. Nat Commun3, 1009.
44.
ChengN, CaiH, BelluscioL (2011) In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function. J Neurosci31, 13699–13704.
45.
ChengN, JiaoS, GumasteA, BaiL, BelluscioL (2016) APP overexpression causes abeta-independent neuronal death through intrinsic apoptosis pathway. eNeuro3, ENEURO.0150-16.2016.
46.
KimJ, ChoiIY, DuffKE, LeeP (2017) Progressive pathological changes in neurochemical profile of the hippocampus and early changes in the olfactory bulbs of tau transgenic mice (rTg4510). Neurochem Res42, 1649–1660
.
47.
YooSJ, LeeJH, KimSY, SonG, KimJY, ChoB, YuSW, ChangKA, SuhYH, MoonC (2017) Differential spatial expression of peripheral olfactory neuron-derived BACE1 induces olfactory impairment by region-specific accumulation of beta-amyloid oligomer. Cell Death Dis8, e2977.
48.
McClintockTS, KhanN, XieC, MartensJR (2020) Maturation of the olfactory sensory neuron and its cilia. Chem Senses45, 805–822.
49.
SchwobJE, JangW, HolbrookEH, LinB, HerrickDB, PetersonJN, Hewitt ColemanJ (2017) Stem and progenitor cells of the mammalian olfactory epithelium: Taking poietic license. J Comp Neurol525, 1034–1054.
50.
HolbrookEH, RebeizL, SchwobJE (2016) Office-based olfactory mucosa biopsies. Int Forum Allergy Rhinol6, 646–653.
51.
JafekBW, MurrowB, MichaelsR, RestrepoD, LinschotenM (2002) Biopsies of human olfactory epithelium. Chem Senses27, 623–628.
52.
GraziadeiPP, GraziadeiGA (1979) Neurogenesis and neuron regeneration in the olfactory system of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory sensory neurons. J Neurocytol8, 1–18.
53.
MoultonDG (1974) Dynamics of cell populations in the olfactory epithelium. Ann N Y Acad Sci237, 52–61.
LirazO, Boehm-CaganA, MichaelsonDM (2013) ApoE4 induces Abeta42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice. Mol Neurodegener8, 16.
56.
Arbones-MainarJM, JohnsonLA, AltenburgMK, KimHS, MaedaN (2010) Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4. FASEB J24, 3809–3818.
57.
DumanBS, OzturkM, YilmazerS, HatemiH (2004) Apolipoprotein E polymorphism in Turkish subjects with Type 2 diabetes mellitus: Allele frequency and relation to serum lipid concentrations. Diabetes Nutr Metab17, 267–274.
58.
ElosuaR, DemissieS, CupplesLA, MeigsJB, WilsonPW, SchaeferEJ, CorellaD, OrdovasJM (2003) Obesity modulates the association among APOE genotype, insulin, and glucose in men. Obes Res11, 1502–1508.
59.
JonesNS, RebeckGW (2018) The synergistic effects of APOE genotype and obesity on Alzheimer’s disease risk. Int J Mol Sci20, 63.
60.
van der LindenC, JakobS, GuptaP, DulacC, SantoroSW (2018) Sex separation induces differences in the olfactory sensory receptor repertoires of male and female mice. Nat Commun9, 5081.
61.
VihaniA, HuXS, GundalaS, KoyamaS, BlockE, MatsunamiH (2020) Semiochemical responsive olfactory sensory neurons are sexually dimorphic and plastic. Elife9, e54501.
62.
DennisGJr., ShermanBT, HosackDA, YangJ, GaoW, LaneHC, LempickiRA (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol4, P3.
NickellMD, BrehenyP, StrombergAJ, McClintockTS (2012) Genomics of mature and immature olfactory sensory neurons. J Comp Neurol520, 2608–2609.
66.
SammetaN, HardinDL, McClintockTS (2010) Uncx regulates proliferation of neural progenitor cells and neuronal survival in the olfactory epithelium. Mol Cell Neurosci45, 398–407.
67.
SammetaN, McClintockTS (2010) Chemical stress induces the unfolded protein response in olfactory sensory neurons. J Comp Neurol518, 1825–1836.
68.
CheongJW, ChongSY, KimJY, EomJI, JeungHK, MaengHY, LeeST, MinYH (2003) Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. Clin Cancer Res9, 5018–5027.
69.
HendzelMJ, WeiY, ManciniMA, Van HooserA, RanalliT, BrinkleyBR, Bazett-JonesDP, AllisCD (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma106, 348–360.
70.
HuBR, LiuCL, OuyangY, BlomgrenK, SiesjoBK (2000) Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab20, 1294–1300.
71.
KaiserCL, ChapmanBJ, GuidiJL, TerryCE, MangiardiDA, CotancheDA (2008) Comparison of activated caspase detection methods in the gentamicin-treated chick cochlea. Hear Res240, 1–11.
72.
ReimanEM, CaselliRJ, YunLS, ChenK, BandyD, MinoshimaS, ThibodeauSN, OsborneD (1996) Preclinical evidence of Alzheimer’s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med334, 752–758.
73.
ReimanEM, ChenK, AlexanderGE, CaselliRJ, BandyD, OsborneD, SaundersAM, HardyJ (2004) Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer’s dementia. Proc Natl Acad Sci U S A101, 284–289.
74.
SmallGW, ErcoliLM, SilvermanDH, HuangSC, KomoS, BookheimerSY, LavretskyH, MillerK, SiddarthP, RasgonNL, MazziottaJC, SaxenaS, WuHM, MegaMS, CummingsJL, SaundersAM, Pericak-VanceMA, RosesAD, BarrioJR, PhelpsME (2000) Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease. Proc Natl Acad Sci U S A97, 6037–6042.
DibattistaM, PifferiS, MeniniA, ReisertJ (2020) Alzheimer’s disease: What can we learn from the peripheral olfactory system?Front Neurosci14, 440.
78.
Ibarra-SoriaX, LevitinMO, SaraivaLR, LoganDW (2014) The olfactory transcriptomes of mice. PLoS Genet10, e1004593.
79.
WangQ, TitlowWB, McClintockDA, StrombergAJ, McClintockTS (2017) Activity-dependent gene expression in the mammalian olfactory epithelium. Chem Senses42, 611–624.
80.
HeronPM, StrombergAJ, BrehenyP, McClintockTS (2013) Molecular events in the cell types of the olfactory epithelium during adult neurogenesis. Mol Brain6, 49.
81.
SaraivaLR, Ibarra-SoriaX, KhanM, OmuraM, ScialdoneA, MombaertsP, MarioniJC, LoganDW (2015) Hierarchical deconstruction of mouse olfactory sensory neurons: From whole mucosa to single-cell RNA-seq. Sci Rep5, 18178.
KnockaertL, DescatoireV, VadrotN, FromentyB, RobinMA (2011) Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen. Toxicol In Vitro25, 475–484.
84.
MatsuuraK, BunaiY, OhyaI, HaraA, NakanishiM, SawadaH (1994) Ultrastructural localization of carbonyl reductase in mouse lung. Histochem J26, 311–316.
NathanBP, NannapaneniS, GairheS, NwosuI, StrubleRG (2007) The distribution of apolipoprotein E in mouse olfactory epithelium. Brain Res1137, 78–83.
95.
EastBS, FlemingG, PengK, OlofssonJK, LevyE, MathewsPM, WilsonDA (2018) Human Apolipoprotein E genotype differentially affects olfactory behavior and sensory physiology in mice. Neuroscience380, 103–110.
96.
AbrahamCR, McGrawWT, SlotF, YaminR (2000) Alpha 1-antichymotrypsin inhibits A beta degradation and in vivo. Ann N Y Acad Sci920, 245–248.
97.
GooptuB, LomasDA (2009) Conformational pathology of the serpins: Themes, variations, and therapeutic strategies. Annu Rev Biochem78, 147–176.
98.
MuckeL, YuGQ, McConlogueL, RockensteinEM, AbrahamCR, MasliahE (2000) Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol157, 2003–2010.
99.
Sanchez-NavarroA, Gonzalez-SoriaI, Caldino-BohnR, BobadillaNA (2021) An integrative view of serpins in health and disease: The contribution of SerpinA3. Am J Physiol Cell Physiol320, C106–C118.
100.
BrandonJA, FarmerBC, WilliamsHC, JohnsonLA (2018) APOE and Alzheimer’s disease: Neuroimaging of metabolic and cerebrovascular dysfunction. Front Aging Neurosci10, 180.
101.
WolfAB, CaselliRJ, ReimanEM, VallaJ (2013) APOE and neuroenergetics: An emerging paradigm in Alzheimer’s disease. Neurobiol Aging34, 1007–1017.
LeungTM, NietoN (2013) CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease. J Hepatol58, 395–398.
105.
SharmaG, ShinEJ, SharmaN, NahSY, MaiHN, NguyenBT, JeongJH, LeiXG, KimHC (2021) Glutathione peroxidase-1 and neuromodulation: Novel potentials of an old enzyme. Food Chem Toxicol148, 111945.
106.
ZhaoS, DevegaR, FrancoisA, KidaneD (2021) Human ALKBH6 is required for maintenance of genomic stability and promoting cell survival during exposure of alkylating agents in pancreatic cancer. Front Genet12, 635808.
107.
ChungJ, ZhangX, AllenM, WangX, MaY, BeechamG, MontineTJ, YounkinSG, DicksonDW, GoldeTE, PriceND, Ertekin-TanerN, LunettaKL, MezJ, Alzheimer’s Disease Genetics Consortium, MayeuxR, HainesJL, Pericak-VanceMA, SchellenbergG, JunGR, FarrerLA (2018) Genome-wide pleiotropy analysis of neuropathological traits related to Alzheimer’s disease. Alzheimers Res Ther10, 22.
108.
DaltonRP, LomvardasS (2015) Chemosensory receptor specificity and regulation. Annu Rev Neurosci38, 331–349.
